DE69704426T2 - Verfahren zur herstellung von medizinischem kaugummi mit einem guten geschmack, enthaltend eine einschlussverbindung - Google Patents

Verfahren zur herstellung von medizinischem kaugummi mit einem guten geschmack, enthaltend eine einschlussverbindung

Info

Publication number
DE69704426T2
DE69704426T2 DE69704426T DE69704426T DE69704426T2 DE 69704426 T2 DE69704426 T2 DE 69704426T2 DE 69704426 T DE69704426 T DE 69704426T DE 69704426 T DE69704426 T DE 69704426T DE 69704426 T2 DE69704426 T2 DE 69704426T2
Authority
DE
Germany
Prior art keywords
chewing gum
gum
active agent
good taste
producing medical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69704426T
Other languages
English (en)
Other versions
DE69704426D1 (de
Inventor
Emilio Testa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Atp Avant Garde Technologies &
Original Assignee
Atp Avant Garde Technologies &
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24594294&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69704426(T2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Atp Avant Garde Technologies & filed Critical Atp Avant Garde Technologies &
Publication of DE69704426D1 publication Critical patent/DE69704426D1/de
Application granted granted Critical
Publication of DE69704426T2 publication Critical patent/DE69704426T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A61K9/0058—Chewing gums
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nanotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medical Informatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Confectionery (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE69704426T 1996-05-03 1997-04-28 Verfahren zur herstellung von medizinischem kaugummi mit einem guten geschmack, enthaltend eine einschlussverbindung Expired - Fee Related DE69704426T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/646,744 US5866179A (en) 1996-05-03 1996-05-03 Medicated chewing gum and a process for preparation thereof
PCT/IB1997/000449 WO1997041843A2 (en) 1996-05-03 1997-04-28 Medicated chewing gum with a pleasant taste containing an inclusion complex

Publications (2)

Publication Number Publication Date
DE69704426D1 DE69704426D1 (de) 2001-05-03
DE69704426T2 true DE69704426T2 (de) 2001-11-15

Family

ID=24594294

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69704426T Expired - Fee Related DE69704426T2 (de) 1996-05-03 1997-04-28 Verfahren zur herstellung von medizinischem kaugummi mit einem guten geschmack, enthaltend eine einschlussverbindung

Country Status (11)

Country Link
US (1) US5866179A (de)
EP (1) EP0909166B1 (de)
JP (1) JP2001506227A (de)
AT (1) ATE200024T1 (de)
CA (1) CA2196150C (de)
DE (1) DE69704426T2 (de)
DK (1) DK0909166T3 (de)
ES (1) ES2157566T3 (de)
GR (1) GR3036117T3 (de)
PT (1) PT909166E (de)
WO (1) WO1997041843A2 (de)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10300187A1 (de) * 2003-01-08 2004-08-26 Cognis Deutschland Gmbh & Co. Kg Kaugummizusammensetzung mit pflanzlichen Wirkstoffen
DE10312173A1 (de) * 2003-03-19 2004-09-30 Ingo Hornung Kaugummi mit beigemengten Mitteln

Families Citing this family (79)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE1011251A3 (fr) 1997-07-03 1999-06-01 Ucb Sa Compositions pharmaceutiques administrables par voie orale, comprenant une substance active et une cyclodextrine.
IT1298732B1 (it) * 1998-03-13 2000-02-02 Recordati Chem Pharm Composizioni farmaceutiche orali assumibili senza liquidi,contenenti complessi di inclusione
AU6412299A (en) * 1998-10-08 2000-04-26 Biovail Technologies Limited Composition and method for medicated chewing gum delivery system
US6531114B1 (en) 1999-04-06 2003-03-11 Wm. Wrigley Jr. Company Sildenafil citrate chewing gum formulations and methods of using the same
US6627234B1 (en) 1998-12-15 2003-09-30 Wm. Wrigley Jr. Company Method of producing active agent coated chewing gum products
US7163705B2 (en) * 1998-12-15 2007-01-16 Wm. Wrigley Jr. Company Coated chewing gum product and method of making
US6586023B1 (en) 1998-12-15 2003-07-01 Wm. Wrigley Jr. Company Process for controlling release of active agents from a chewing gum coating and product thereof
US6426090B1 (en) * 1999-04-06 2002-07-30 Wm. Wrigley Jr. Company Over-coated product including tableted center and medicament
US6773716B2 (en) 1999-04-06 2004-08-10 Wm. Wrigley Jr. Company Over-coated chewing gum formulations
US20020159956A1 (en) * 1999-04-06 2002-10-31 Ream Ronald L. Over-coated chewing gum formulations
US6355265B1 (en) 1999-04-06 2002-03-12 Wm. Wrigley Jr. Company Over-coated chewing gum formulations
US6322806B1 (en) 1999-04-06 2001-11-27 Wm. Wrigley Jr. Company Over-coated chewing gum formulations including tableted center
US7935362B2 (en) * 1999-04-06 2011-05-03 Wm. Wrigley Jr. Company Over-coated product including consumable center and medicament
US20040220151A1 (en) * 1999-06-28 2004-11-04 Minu, L.L.C. Process for treating tissue and suppressing pain
US20040219110A1 (en) * 1999-06-28 2004-11-04 Minu , L.L.C. Process for removing calculus deposits from the teeth and suppressing pain
US6436429B1 (en) 1999-06-28 2002-08-20 Gholam A. Peyman Process and composition for temporarily suppressing pain
US6645535B2 (en) 1999-09-02 2003-11-11 Wm. Wrigley Jr. Company Method of making coated chewing gum products containing various antacids
US6663849B1 (en) 2000-09-01 2003-12-16 Wm. Wrigley Jr. Company Antacid chewing gum products coated with high viscosity materials
US6569472B1 (en) 2000-09-01 2003-05-27 Wm. Wrigley Jr. Company Coated chewing gum products containing antacid and method of making
US6541048B2 (en) 1999-09-02 2003-04-01 Wm. Wrigley Jr. Company Coated chewing gum products containing an acid blocker and process of preparing
US9387168B2 (en) 1999-09-20 2016-07-12 Jack Barreca Chewing gum with tomatidine
US9253991B2 (en) 1999-09-20 2016-02-09 Jack Barreca Chewing gum with B vitamins
WO2001021147A1 (en) * 1999-09-20 2001-03-29 Mastercare Diet and weight control gum and sucker
US6905672B2 (en) * 1999-12-08 2005-06-14 The Procter & Gamble Company Compositions and methods to inhibit tartar and microbes using denture adhesive compositions with colorants
US6350480B1 (en) 1999-12-30 2002-02-26 Wm. Wrigley Jr. Company Chewing gum product including a hydrophilic gum base and method of producing
DE10013712A1 (de) * 2000-03-20 2001-09-27 Nutrinova Gmbh Nikotinsalze mit verbessertem Geschmack, Verfahren zu ihrer Herstellung und ihre Verwendung
US6582717B1 (en) * 2000-04-07 2003-06-24 Massachusetts Institute Of Technology Drug delivery composition and device
US6572900B1 (en) 2000-06-09 2003-06-03 Wm. Wrigley, Jr. Company Method for making coated chewing gum products including a high-intensity sweetener
US7115288B2 (en) * 2000-06-09 2006-10-03 Wm. Wrigley Jr. Company Method for making coated chewing gum products with a coating including an aldehyde flavor and a dipeptide sweetener
US6444241B1 (en) 2000-08-30 2002-09-03 Wm. Wrigley Jr. Company Caffeine coated chewing gum product and process of making
US6579545B2 (en) 2000-12-22 2003-06-17 Wm. Wrigley Jr. Company Coated chewing gum products containing an antigas agent
GB0107954D0 (en) * 2001-03-29 2001-05-23 Nestle Sa Chewing gum-containing tablet
KR20010069587A (ko) * 2001-04-18 2001-07-25 전창호 껌의 조성물
US7208186B2 (en) * 2001-09-18 2007-04-24 Spi Pharma, Inc. Chewing gum formulation and method of making the same
US20030086999A1 (en) * 2001-09-18 2003-05-08 Norman Gary T. Chewing gum formulation and method of making the same
AU2003201161B2 (en) * 2002-01-15 2008-02-28 Ucb Farchim S.A. Formulations
DK1517616T3 (en) * 2002-07-02 2017-06-19 Fertin Pharma As COMPRESSED CHEW GUM TABLE II
US20050175733A1 (en) * 2002-07-02 2005-08-11 Bitten Thorengaard Compressed resin moderated chewing gum
US20060115433A1 (en) * 2002-07-02 2006-06-01 Andersen Rita B Compressed chewing gum
KR101109155B1 (ko) * 2002-07-02 2012-06-20 굼링크 에이/에스 수지로 부드럽게 만든 압축 츄잉 검
GB0216413D0 (en) * 2002-07-15 2002-08-21 Nestle Sa Tabletted chewing gum sweet
WO2004028267A1 (en) * 2002-09-24 2004-04-08 Gumlink A/S Chewing gum having improved release of chewing gum ingredients
ES2311631T3 (es) * 2002-09-24 2009-02-16 Gumlink A/S Goma de mascar biodegradable que comprende por lo menos un polimero biodegradable de alto peso molecular.
ATE407568T1 (de) * 2002-09-24 2008-09-15 Gumlink As Kaugummi mit niedrigem feuchtigkeitsgehalt
ES2578252T3 (es) 2002-09-24 2016-07-22 Gumlink A/S Goma de mascar que comprende al menos dos polímeros biodegradables diferentes
AU2002342580B2 (en) * 2002-09-24 2008-05-15 Gumlink A/S Degradable chewing gum polymer
WO2004040994A1 (en) * 2002-11-06 2004-05-21 Firmenich Sa Gum base composition
US8602774B2 (en) 2002-12-04 2013-12-10 Bryan Wasylucha Process of tooth whitening and apparatus therefor
WO2004068965A1 (en) * 2003-02-04 2004-08-19 Gumlink A/S Compressed chewing gum tablet
DK1474993T3 (da) * 2003-05-06 2009-01-12 Gumlink As Fremgangsmåde til fremstilling af tyggegummigranuler og kornprimerede tyggegummiprodukter, og et tyggegummigranuleringssystem
DK1474995T3 (da) * 2003-05-06 2013-02-18 Gumlink As Fremgangsmåde til fremstilling af tyggegummigranulater, et gummisammensætningsekstruder- og granuleringssystem og et tyggegummiprodukt
BR0318707A (pt) * 2003-12-30 2006-12-19 Gumlink As goma de mascar, uso de pelo menos uma enzima, e método para degradação de uma goma de mascar biodegradável
ATE480150T1 (de) * 2003-12-30 2010-09-15 Gumlink As Komprimierbarer biologisch abbaubarer kaugummi
WO2006012213A2 (en) * 2004-06-25 2006-02-02 Tea Guard Llc Composition and method for delivery of phytochemicals
JP4875616B2 (ja) 2004-07-06 2012-02-15 ガムリンク エー／エス 圧縮チューインガムタブレット
DK200401195A (da) * 2004-08-06 2004-08-06 Gumlink As Layered chewing gum tablet
EP1866402B2 (de) * 2005-03-22 2013-01-30 Gumlink A/S Verfahren zur reinigung einer mit mindestens einem kaugummiklumpen verklebten oberfläche
US20090065745A1 (en) * 2005-03-31 2009-03-12 Hirotsugu Kido Anti-degradation agent
CA2654325A1 (en) * 2006-06-16 2007-12-21 Gumlink A/S Chewing gum comprising a hydrophobic enzyme formulation
JP4709730B2 (ja) * 2006-11-15 2011-06-22 新田ゼラチン株式会社 チュアブルタブレット
US20080286340A1 (en) * 2007-05-16 2008-11-20 Sven-Borje Andersson Buffered nicotine containing products
WO2009007770A1 (en) * 2007-07-06 2009-01-15 Gumlink A/S Chewing gum granules for compressed chewing gum
EP2162013B1 (de) * 2007-07-06 2016-04-06 Gumlink A/S Komprimierter kaugummi mit einem naturharz umfassenden verkapselungsdarreichungssystem
WO2009006898A1 (en) * 2007-07-11 2009-01-15 Fertin Pharma A/S Stable medicated chewing gum comprising cyclodextrin inclusion complex
DK2229156T3 (en) * 2007-12-20 2017-02-06 Fertin Pharma As CHEW GUM TABLE AND PROCEDURE FOR DOSING PHARMACEUTICAL ACTIVE INGREDIENTS IN SUCH CHEW GUM TABLE
WO2009080021A1 (en) 2007-12-20 2009-07-02 Fertin Pharma A/S Compressed chewing gum tablet
WO2009080022A1 (en) * 2007-12-20 2009-07-02 Fertin Pharma A/S Compressed chewing gum tablet
DK2282645T3 (en) * 2008-05-26 2015-07-13 Fertin Pharma As Flavor impregnation of a chewing gum
US8506936B2 (en) * 2008-11-25 2013-08-13 Watson Laboratories, Inc. Stabilized nicotine chewing gum
WO2010069311A1 (en) 2008-12-19 2010-06-24 Fertin Pharma A/S Multi-part kit
KR101138851B1 (ko) * 2009-04-27 2012-05-09 김만규 금연 껌 조성물 및 그를 이용한 금연 껌 제조방법
KR20120024689A (ko) * 2009-05-01 2012-03-14 바스프 코포레이션 이산화염소 기재 검 및 캔디
US20110038915A1 (en) * 2009-08-14 2011-02-17 Eduardo Jose Gonzalez Chewing Gum Formula for Enhancing Psycho-Spirituality
US20130101527A1 (en) * 2011-10-14 2013-04-25 Rodolfo R. Llinas Methods, compounds and pharmaceutical compositions for treating neurological disorders
WO2014086358A1 (en) * 2012-12-07 2014-06-12 Gumlink A/S Compressed tablets
EP2808319A1 (de) * 2013-05-31 2014-12-03 Arevipharma GmbH 3-[3-(dimethylamin)-1-ethyl-2-methylpropyl]phenolharzkomplex
US9744128B2 (en) 2014-06-05 2017-08-29 Mastix LLC Method for manufacturing medicated chewing gum without cooling
US10765658B2 (en) 2016-06-22 2020-09-08 Mastix LLC Oral compositions delivering therapeutically effective amounts of cannabinoids
WO2018160043A1 (ko) * 2017-03-03 2018-09-07 주식회사 씨티씨바이오 바레니클린 또는 이의 약학적으로 허용가능한 염의 포접 복합체를 포함하는 구강 투여용 제제

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3262784A (en) * 1963-12-02 1966-07-26 Frank H Fleer Corp Chewing gum product and method of making same
US4068004A (en) * 1976-06-30 1978-01-10 Life Savers, Inc. System and method for cooling of gum base
US4161546A (en) * 1977-08-03 1979-07-17 Standard Oil Company (Indiana) Process for texturizing proteinaceous materials
US4348416A (en) * 1980-08-07 1982-09-07 International Flavors & Fragrances Inc. Flavoring with 1-ethoxy-1-ethanol acetate - acetaldehyde mixtures
CA1240875A (en) * 1984-01-31 1988-08-23 Subraman R. Cherukuri Tableted chewing gum composition and method of preparation
JPH0826345B2 (ja) * 1986-07-10 1996-03-13 株式会社林原生物化学研究所 固状油溶性物質の製造方法
US5370881A (en) * 1987-04-20 1994-12-06 Fuisz Technologies Ltd. Water-soluble delivery systems for hydrophobic liquids
JP2545559B2 (ja) * 1987-05-02 1996-10-23 和也 小山 チューインガム成形における離型方法
US5229148A (en) * 1989-04-19 1993-07-20 Wm. Wrigley Jr. Company Method of combining active ingredients with polyvinyl acetates
JPH07583B2 (ja) * 1990-11-21 1995-01-11 北海道糖業株式会社 水溶性五環性トリテルペン包接化合物及びその製造方法並びにそれを利用した食品、飲料、口腔用組成物
US5165943A (en) * 1991-06-21 1992-11-24 Wm. Wrigley Jr. Company Cooling agent/cyclodextrin complex for improved flavor release
NZ243667A (en) * 1991-08-02 1995-02-24 Kurihara Yoshie Chewing gum containing coated curculin derivative or fruit containing curculin
DE4220735A1 (de) * 1992-06-25 1994-01-13 Puetter Medice Chem Pharm Kaugummizubereitungen
WO1995003709A1 (fr) * 1993-07-30 1995-02-09 Firmenich S.A. Procede d'aromatisation
US5362496A (en) * 1993-08-04 1994-11-08 Pharmetrix Corporation Method and therapeutic system for smoking cessation

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10300187A1 (de) * 2003-01-08 2004-08-26 Cognis Deutschland Gmbh & Co. Kg Kaugummizusammensetzung mit pflanzlichen Wirkstoffen
DE10300187B4 (de) * 2003-01-08 2007-03-29 Cognis Ip Management Gmbh Kaugummizusammensetzung mit pflanzlichen Wirkstoffen
DE10312173A1 (de) * 2003-03-19 2004-09-30 Ingo Hornung Kaugummi mit beigemengten Mitteln

Also Published As

Publication number Publication date
DE69704426D1 (de) 2001-05-03
MX9703317A (es) 1998-06-30
WO1997041843A3 (en) 1997-12-11
DK0909166T3 (da) 2001-08-13
JP2001506227A (ja) 2001-05-15
PT909166E (pt) 2001-09-28
US5866179A (en) 1999-02-02
EP0909166A2 (de) 1999-04-21
EP0909166B1 (de) 2001-03-28
GR3036117T3 (en) 2001-09-28
CA2196150A1 (en) 1997-11-04
WO1997041843A2 (en) 1997-11-13
ES2157566T3 (es) 2001-08-16
ATE200024T1 (de) 2001-04-15
CA2196150C (en) 2003-04-15

Similar Documents

Publication Publication Date Title
DE69704426D1 (de) Verfahren zur herstellung von medizinischem kaugummi mit einem guten geschmack, enthaltend eine einschlussverbindung
ATE82495T1 (de) Verfahren zur herstellung pharmazeutischer mischungen.
ATE421318T1 (de) Darreichungsform, welche rasche dispersionseigenschaften entfaltet, anwendungsverfahren sowie verfahren zur herstellung derselben
ATE62485T1 (de) Indolizin-derivate, verfahren zur herstellung und diese enthaltende zusammensetzungen.
ATA164884A (de) Verfahren zur herstellung von festen, zweiphasigen nifedipinhaltigen arzneimittelzubereitungen
DE3684190D1 (de) Verwendung von tetrahydrobiopterinen zur herstellung eines medikaments zur behandlung von kinderautismus.
ATE184480T1 (de) Verfahren zur herstellung von arzneizubereitungen mit verzögerter wirkstoffabgabe
DE50000866D1 (de) Verfahren zur herstellung von festen cyclodextrinhaltigen dosierungsformen
ATE25525T1 (de) N-glycosylierte carbonsaeureamid-derivate, verfahren zu ihrer herstellung sowie ihre verwendung zur beeinflussung der koerpereigenen abwehr.
DE3872049D1 (de) Alkohol, fett und protein enthaltendes aufschaumbares produkt sowie verfahren zu seiner herstellung.
ATE216576T1 (de) Vehrfahren zur herstellung von beta-lactam antibiotikum enthaltenden oralen dosisformen
DE60211769D1 (de) Verfahren zur Herstellung von Arzneistoffgranulatkörnern, die Arzneistoffgranulatkörner sowie diese enthaltende pharmazeutische Zubereitungen
DE69527711D1 (de) Verfahren und apparat zur herstellung von schnelllöslichen dosierungseinheiten und daraus erhältliches produkt
ATE100095T1 (de) 2,2-dimethylchromenderivate, verfahren zur herstellung und diese enthaltende pharmazeutische zusammenstellungen.
DE2920890A1 (de) Neue physiologisch aktive derivate des esterastins sowie verfahren zur herstellung derselben
DE68917937D1 (de) Verbindungen mit magensäureinhibitorwirkung und verfahren zur herstellung.
ATE15897T1 (de) Ausgangsprodukte zur herstellung von cephalosporinen und verfahren zu ihrer herstellung.
DE68924011D1 (de) Verfahren zur Herstellung von Pyrazolkarbonsäure und Derivaten.
DE59002265D1 (de) Kaugummi zur mund- und rachendesinfektion, sowie verfahren zu seiner herstellung.
DE69631169D1 (de) Herstellung von (s)-decahydroisochinolin-3-carbonsäure-t-butylamid
ATE109137T1 (de) Pyridinderivate, verfahren zur herstellung und pharmazeutische zusammensetzungen.
DE60141089D1 (de) Verfahren zur herstellung von medizinischem kaugummi
ATE305799T1 (de) Stabilisierte pharmazeutische zusammensetzungen und verfahren zu ihrer herstellung, mit einem antibiotikum und einem expektorans
DE68914660D1 (de) Verfahren zur Herstellung von den Safranblütennarben ähnlichem Gewebe sowie Verfahren zur Herstellung von nützlichen Stoffen aus safranblütennarbenähnlichem Gewebe.
DE69719049T2 (de) Pharmazeutische zusammensetzung, enthaltend komplementproteine, zur behandlung von helicobacter-infektionensowie ein verfahren zur herstellung der zusammensetzung

Legal Events

Date Code Title Description
8363 Opposition against the patent
8339 Ceased/non-payment of the annual fee